12 Best 52-Week Low Stocks to Buy According to Analysts

8. Globus Medical, Inc. (NYSE:GMED)

Price: $57.12  

52-Week Range: 54.48 – 94.93

Number of Hedge Fund Holders: 45

Analyst Upside Potential: 40.06%

Globus Medical, Inc. (NYSE:GMED) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 3, Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Globus Medical, Inc. (NYSE:GMED) with a price target of $80.

The firm maintained a bullish sentiment despite the company posting a weak fiscal first quarter of 2025. Globus Medical, Inc. (NYSE:GMED) posted a revenue of $598.12, slightly down by 1.41% year-over-year, and below consensus by $27.78 million. The EPS of $0.68 also missed the target by -$0.06.

On the bright side, the US sales were steady, rising by 0.2%. Management noted that the main reason for weaker sales was fewer enabling technology deals and some supply chain issues. The timing of orders from international distributors also played a part. Despite these challenges, the company’s US spine business remained strong and offset some of the decline. Management has reaffirmed the full-year guidance and is expecting revenue between $2.8 billion and $2.9 billion.

Globus Medical, Inc. (NYSE:GMED) is a medical device company specializing in developing and commercializing solutions for musculoskeletal disorders.